The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

When Most cancers Makes You Cry, Cry It Out

Felicia Mitchell is a survivor of stage 2b HER2-positive breast most cancers recognized in 2010. Atone for all of Felicia's blogs right here!Typically the...

World Most cancers Day Shines Mild on Therapeutic Developments in Most cancers Care

An skilled mentioned the significance of World Most cancers Day.Picture credit score: Jemastock / Adobe Inventory PhotographsWorld Most cancers Day is widely...

Weight Achieve Measurements Could Be Underreported in ALK+ NSCLC Trials

Research finds Alecensa weight acquire underreported in ALK+ NSCLC trials, urging consciousness and proactive administration as a result of potential long-term well being...

Tevimbra Plus Chemo Could Be Protected, Efficient in Superior Gastric/GEJ Most cancers

Frontline therapy with Tevimbra plus chemotherapy confirmed promising efficacy and manageable security in superior gastric/GEJ most cancers.Amongst sufferers with superior, HER2-negative, mismatch repair-proficient...

Rybrevant Alone and in Combo With Chemo is Efficacious in HER+ mCRC

On the 2025 ASCO Gastrointestinal Cancers Symposium, investigators, equivalent to Dr. Filippo Pietrantonio, shared knowledge on the OrigAMI-1 trial which assessed Rybrevant (amivantamab)...

Hot Topics